News + Filings IR Vault
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
Inv. presentation
Appointed director
Director departure
Credit agrmnt [a]
Asset disposition
Acq. announced
Appointed CFO
Consulting agrmnt
Auditor change
Notes underwriting agrmnt
Director comp.
Employment agrmnt
Dividend declared
Appointed COO
Filed Chapter 11
Monthly dividend
Preliminary results
Accel. buyback
Cert. of designation
Acq. completed
Monthly oper. report
Merger agrmnt [a]
Quarterly results presentation
Class action filed
CFO resigned
Departure of a VP
SSS news release
Asset acq. complete
Letter to company
Buyback announced
Bonus plan approved
Upcoming conference date
Notes have priced
Coll. bargaining agrmnt
10-Q late filing
RE purchase
Amended bylaws
New credit facility
|
|
All Companies
|
Create: Portfolio | Alert |
All | News | Filings
| Date Filed | Symbol | Type | Description |
| 11/15/2019 |
RES
|
8-K
| Quarterly results |
| 11/15/2019 |
MPX
|
8-K
| Quarterly results |
| 06/11/2019 |
MPX
|
8-K
| Announced their attendance at an upcoming conference |
| 03/28/2019 |
SYNC
|
8-K
| Announced their attendance at an upcoming conference |
| 05/23/2016 |
MPX
|
8-K
| Form 8-K - Current report |
| 02/04/2016 |
CORX
|
8-K
| Announced their attendance at an upcoming conference|
Docs:
|
"Slide Presentation",
"RespireRx Pharmaceuticals Inc. to Present at 18 th Annual BIO CEO & Investor Conference GLEN ROCK, NJ-- – RespireRx Pharmaceuticals Inc. , a leader in the development of medicines for respiratory disorders, including sleep apneas and drug-induced respiratory depression, announces that the Company’ s President & CEO and Vice Chairman of the Board of Directors, James S. Manuso, Ph.D., will present at the 18 th Annual BIO CEO & Investor Conference in New York City on Monday, February 8, 2016 at 10:00 AM Eastern Standard Time. The Conference is sponsored by the Biotechnology Innovation Organization and will be held at the Waldorf Astoria Hotel, on February 8 and 9, 2016. Stated Dr. Manuso, “The BIO CEO conference provides an excellent forum for updating investors on our ongoing research and de..." |
|
| 10/06/2015 |
TRU
|
8-K
| Announced their attendance at an upcoming conference |
| 11/18/2013 |
CORR
|
8-K
| Announced their attendance at an upcoming conference |
| 05/29/2012 |
LAD
|
8-K
| Announced their attendance at an upcoming conference |
| 11/23/2011 |
TMRC
|
8-K
| Form 8-K - Current report |
| 03/01/2011 |
HFFC
|
8-K
| Form 8-K - Current report |
| 11/24/2009 |
CRBC
|
8-K
| Investor presentation, Announced their attendance at an upcoming conference |
| 05/15/2008 |
OKE
|
8-K
| Form 8-K - Current report |
| 05/15/2008 |
OKS
|
8-K
| Announced their attendance at an upcoming conference |
| 11/23/2007 |
QRCP
|
8-K
| Announced their attendance at an upcoming conference |
| 01/12/2006 |
EDGW
|
8-K
| Form 8-K - Current report |
| 02/23/2004 |
PRCS
|
8-K
| Announced their attendance at an upcoming conference |
| 02/28/2002 |
PARD
|
8-K
| Announced their attendance at an upcoming conference |
|
|